APAC IPOs & Placements, Aequitas Research

Clarence Chu

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

ACommerce Pre-IPO - Updates Since Our Last Note - Probably Has to Scale Further to Become Profitable

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/acommerce-group" target="_blank" data-smartkarma-citation="entities:35789:1" rel="noopener">ACommerce Group (ACOM TB)</a> is looking to raise about US$200m in its upcoming Thailand IPO.</li>
<li>Acommerce is an ecommerce enabler providing end-to-end and ala carte ecommerce solutions for brands in Southeast Asia (SEA). </li>
<li>Acommerce has been a key beneficiary of COVID, however, has been recording unexpectedly weak margins, suggesting that it does a lot of logistical heavy lifting. </li>
</ul>



ACommerce Group (ACOM TB) is looking to raise about US$200m in its upcoming Thailand IPO.
Acommerce is an ecommerce enabler providing end-to-end and ala carte ecommerce solutions for brands in Southeast Asia (SEA). 
Acommerce has been a key beneficiary of COVID, however, has been recording unexpectedly weak margins, suggesting that it does a lot of logistical heavy lifting. 


Acommerce Pre-IPO - Beneficiary of COVID However, Has Been Losing Market Share

aCommerce Group

Acommerce Pre-IPO - Beneficiary of COVID However, Has Been Losing Market Share